Pulmonx

Pulmonx Corporation, based in Redwood City, California, specializes in innovative treatments for patients suffering from severe chronic obstructive pulmonary disease (COPD) and emphysema. The company's flagship product, the Zephyr Valve, is a clinically-proven bronchoscopic treatment designed to alleviate breathlessness without the need for invasive surgery.

Renowned for its safety and efficacy, the Zephyr Valve has demonstrated significant improvements in lung function, exercise capacity, and overall quality of life for patients. Through ongoing research and clinical trials, Pulmonx remains committed to selecting appropriate candidates for their groundbreaking treatment, ultimately helping individuals lead more active and fulfilling lives.

Generated from the website